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Abstract 
 
Chapter 1. We have developed a catalytic method for enantio- and SN2’-selective allylic 
substitution of commercially available diborylmethane to trisubstituted allylic phosphates 
(pin = pinacolato). The transformations are catalyzed by NHC–Cu complexes (NHC = N-
heterocyclic carbene). Products bearing quaternary stereogenic carbon centers are 
obtained in up to 86% yield (after oxidation), >98:2 SN2’/SN2 selectivity and 95:5 
enantiomeric ratio (e.r.). 
 
 
Chapter 2. We have developed a facile multicomponent catalytic process that begins 
with a chemo- and site-selective copper–hydride addition to allenyl-B(pin) followed by 
enantioselective conjugate addition of the resulting allylcopper intermediate to α,β-
 ii 
unsaturated malonate, generating products that contain a stereogenic center and an easily 
functionalizable alkenyl-B(pin) group in up to 84% yield, >98:2 E/Z selectivity and 96:4 
enantiomeric ratio. The transformations are catalyzed by chiral Cu complexes derived 
from commercially available bisphosphines and CuCl. 
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CHAPTER 1                                                                                                       
SYNTHESIS OF ALKYL-B(PIN) WITH AN ALL-CARBON 
QUATERNARY STEREOGENIC CENTER BY CATALYTIC 
ENANTIOSELECTIVE ALLYLIC SUBSTITUTION WITH A 
DIBORYLMETHANE REAGENT  
1.1 INTRODUCTION 
One of the significant challenges in chemical synthesis is the development of 
efficient catalytic enantioselective reactions that furnish all-carbon quaternary stereogenic 
centers.1  A general strategy for promoting such processes is the addition of carbon-based 
nucleophiles to electrophilic carbon sites. Copper-catalyzed enantioselective allylic 
substitution (EAS) is one of the most powerful carbon-carbon bond-forming reactions for 
the construction of stereogenic centers at the allylic position.2  Significant progress has 
                                                        
(1) (a) Quaternary Stereocenters: Challenges and Solutions for Organic Synthesis; Christophers, J., 
Baro, A., Eds.; Wiley-VCH: Weinheim, 2006. (b) Douglas, C. J.; Overman, L. E. Proc. Natl. Acad. 
Sci. U.S.A. 2004, 101, 5363. (c) Cozzi, P. G.; Hilgraf, R.; Zimmermann, N. Eur. J. Org. Chem. 2007, 
5969. 
(2) For representative reviews, see: (a) Alexakis, A.; Bäckvall, J. E.; Krause, N.; Pàmies, O.; Diéguez, 
M. Chem. Rev. 2008, 108, 2796-2823. (b) Harutyunyan, S. R.; den Hartog, T.; Geurts, K.; Minnaard, 
A. J.; Feringa, B. L. Chem. Rev. 2008, 108, 2824–2852. 
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been made in the enantioselective allylic substitution with organometallic reagents (for 
example, Mg-, Zn-, and Al-based nucleophiles).2 
More recently, methodologies utilizing organoboron reagents, which are more 
functional group tolerant and widely available, such as diborylmethane, have been 
reported. 3  We design the Cu-catalyzed enantioselective allylic substitution with di-
B(pin)-methane to furnish compounds with all-carbon quaternary stereogenic centers as 
well as boronic ester and terminal olefin that can be easily transformed to other functional 
groups. We then applied this method to the synthesis of a bioactive molecule to highlight 
its utility.  
1.2 BACKGROUND 
Diborylmethane reagent 1.2 was first synthesized by Matteson and co-workers in 
1982. 4  Dichloromethane and lithium react with trimethylborate to generate the 
tetramethoxy diborylmethane. Then diborylmethane reagent 1.2 was formed by the 
addition of pinacol to tetramethoxy diborylmethane.  
More recently, there has been reports on allylic substitutions with diborylmethane 
1.2. Cho and co-workers reported an NHC–Cu-catalyzed allylic substitution with 
diborylalkyl reagents (scheme 1.1).3a Alkyl-B(pin) containing products are obtained in up 
to 86% yield and >99:1 SN2’:SN2 selectivity.  
                                                        
(3) For examples of allylic substitution with di-B(pin)-methane, see: (a) Kim, J.; Park, S.; Park, J.; 
Cho, S. H. Angew. Chem., Int. Ed. 2016, 55, 1498–1501. (b) Zhang, Z.; Zhang, B.; Lu, X.; Liu, J.; Lu, 
X.; Xiao, B.; Fu, Y. Org. Lett. 2016, 18, 952-955. (c) Shi, Y.; Hoveyda A. H. Angew. Chem., Int. Ed. 
2016, 55, 3455-3458. (d) Zhan, M.; Li, R. Z.; Mou, Z. D.; Cao, C. G.; Liu, J.; Chen, Y.; Niu, D. ACS 
Catal. 2016, 6, 3381-3386. 
(4) Matteson, D. S.; Moody, R. J. Organometallics 1982, 1, 20–28. 
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Fu and co-workers also reported a similar transformation (scheme 1.2).3b Products 
are obtained in up to 88% yield and 98:2 SN2’:SN2 selectivity. Products containing 
quaternary carbon centers are also generated with high effiency. 
 
Hoveyda and co-workers reported the first enantioselective allylic substitution with 
diborylmethane 1.2 (scheme 1.3).3c A wide range of aryl- and alkyl-substituted allylic 
phosphates can be transformed to products in up to 95% yield (after oxidation), 99:1 e.r. 
and 98:2 SN2’:SN2 selectivity. The author also highlighted the method with the formal 
synthesis of rhopaloic acid A. 
 
Niu and co-workers also reported an Ir-catalyzed enantioselective allylic substitution 
with di-B(pin)-methane (scheme 1.4).3d Products are obtained from aryl allylic carbonates 
 4 
in high effiency and enantiomeric ratio (up to 99% yield and 99:1 e.r.). The alkyl case 
reported is less efficient (one example with 24% NMR yield and N.D. e.r.). 
 
1.3 IDENTIFICATION OF THE OPTIMAL CATALYST FOR CATALYTIC 
ENANTIOSELECTIVE ALLYLIC SUBSTITUTION WITH A 
DIBORYLMETHANE REAGENT 
We started our investigation from ligand screening for the methyleneboryl addition 
to E-allylic phosphate 1.10. A variety of ligands, including different types of NHC-Ag 
complexes and phosphines are tested (table 1.1). The results indicate that phosphines 
deliver exclusively the undesired SN2 products, while NHC-Ag complexes have 
comparatively better SN2’ selectivity. By tuning the substitution patterns on the NHCs, 
different enantiomeric ratios can be achieved. NHC containing a mestiyl group with a 
mono-phenyl backbone N5 showed the highest enantioselectivity (84:16 e.r.) with 56% 
yield of 1.11 after oxidation (entry 5).  
 5 
 
Entry Ligand Conv. %b SN2’:SN2c Yield %d e.r.e 
1 N1 88 93:7 74 78:22 
2 N2 75 83:17 38 75:25 
3 N3 71 5:95 ND NA 
4 N4 62 58:42 33 74:26 
5 N5 72 93:7 56 84:16 
6 N6 79 93:7 69 81:19 
7 N7 65 39:61 25 68:32 
8 N8 74 61:39 36 44:56 
9 N9 84 48:52 33 20:80 
10 N10 72 98:2 60 38:62 
11 N11 73 98:2 52 36:64 
12 BINAPf 52 <2:>98 ND NA 
13 dpppf 63 <2:>98 ND NA 
14 SIMesf 24 <2:>98 ND NA 
a Reactions were performed under N2 atmosphere. b,c Determined by analysis of 400 MHz 1H NMR of 
unpurified mixtures. d Isolated yield after oxidation. e Determined by HPLC analysis. f 5.5 mol % of 
ligand used. 
 
 6 
We then investigated a variety of ligands for the the addition to Z-allylic phosphate 
1.12, since the allylic substitution would generate the same product. As shown in table 
1.2, to our delight, complexes with 3,6-substituted N-Aryl group would lead to higher 
enantioselectivity (90:10 e.r. and 92:8 e.r., entry 7,8), although ligands with other 
substituted patterns afford lower e.r. Among them, N12 promotes an efficient reaction 
with 98:2 SN2’:SN2 selectivity, 80% yield and 92:8 e.r. 
 
Entry Ligand Conv. %b SN2’:SN2c Yield %d e.r.e 
1 N1 68 67:33 25 67:33 
2 N5 67 81:19 38 62:38 
3 N7 70 25:75 13 64: 36 
4 N8 80 3:97 ND ND 
5 N9 72 19:81 12 54:46 
6 N10 70 57:43 36 76:24 
7 N11 86 93:7 76 90:10 
8 N12 98 98:2 80 92:8 
9f N11 <5 NA NA NA 
a Reactions were performed under N2 atmosphere. b,c Determined by analysis of 400 MHz 1H NMR of 
unpurified mixtures. d Isolated yield after oxidation. e Determined by HPLC analysis. f Without CuCl. 
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1.4 SCOPE OF CATALYTIC ENANTIOSELECTIVE ALLYLIC 
SUBSTITUTION WITH A DIBORYLMETHANE REAGENT 
With the optimized conditions in hand, we explored the scope of the 
enantioselective allylic substitution with diborylmethane 1.2. As shown in scheme 1.5, 
halogen-containing substrates are well tolerated (1.11b, 1.11c, 1.11g). Allylic phosphates 
bearing electron-rich and electron-poor arenes are also suitable substrates (1.11d, 1.11e). 
Sterically-demanding substrate with o-OMe substituent 1.11f works well, with a slightly 
lower efficiency (79% yield and 95:5 e.r.). Alkyl allylic phosphate 1.11h also works well 
but with a moderate enantiomeric ratio (84:16 e.r.), probably due to the difficulty in 
differentiating an alkyl group with a methyl group. Additions to most of these substrates 
afford excellent SN2’ selectivities (≥ 98:2), except for electron-deficient p-CF3 containing 
1.11d (85:15), probably because the higher reactivity makes the energetic difference 
between the desired pathway and the background reaction that leads to SN2 product is 
smaller. 
 8 
  
a 7.5 mol % CuCl, 4.1 mol % ligand used. b N11 used instead of N12. c 96 h instead of 24 h. d 48 h 
instead of 24 h. e Isolated yield of pure SN2’ product. 
 
1.5 STEREOCHEMICAL MODEL FOR CATALYTIC ENANTIOSELECTIVE 
ALLYLIC SUBSTITUTION WITH A DIBORYLMETHANE REAGENT 
We then envisioned a stereochemical model for the enantioselective allylic 
substitution which accounts for the observed enantioselectivity. As shown in scheme 1.6, 
 9 
the extended bulky Ar group on the NHC would push the B(pin) moiety away from itself, 
which favors pathway a. The difference between the two substituents with B(pin) (Ph vs 
Me) accounts for the generation of the major enantiomer 1.13. Mechanistic rationale 
accounting for the better performance of Z vs E substrates requires further study. 
 
1.6 APPLICATION IN FORMAL SYNTHESIS OF BIOACTIVE 
MOLECULES  
The terminal olefin and pinacolboronic ester group presented in the products of 
enantioselective allylic substitution provide a potential for conversion to a variety of 
valuable intermediates in the synthesis of natural products and pharmaceuticals. For 
 10 
example, oxidation of compound 1.11 with ozone and hydrogen peroxide produced (R)-
α-methyltropic acid 1.15, 5  which is a key intermediate for the synthesis of (R)-
Atromepine, a drug treating heart rhythm disease (scheme 1.7).6 Our method generates 
the desired compound 1.11 in higher yield and enantiomeric ratio than previous reports. 5 
 
1.7 CONCLUSION  
We have developed a catalytic method for enantio- and SN2’-selective allylic 
substitution of commercially available diborylmethane to trisubstituted allylic phosphates. 
The transformations are catalyzed by NHC–Cu complexes. Products bearing quaternary 
stereogenic carbon centers are obtained in up to 86% yield (after oxidation), >98:2 
SN2’:SN2 selectivity and 95:5 enantiomeric ratio. We applied this method in the formal 
synthesis of bioactive molecule (R)-Atromepine. Further studies on expanding substrate 
scope, mechanistic studies, functionalization of products and application towards the 
synthesis of valuable compounds are in progress. 
                                                        
(5) Zhang, Q.; Zhu, S.; Cai, Y.; Wang, L.; Zhang, Q. Sci China Chem, 2010, 53, 1899-1906. 
(6) Melone G.; Vecchi A.; Pagani G.; Testa E. J. Org. Chem. 1960, 25, 859–861. 
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1.8 EXPERIMENTAL 
General 
Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, νmax in cm−1. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, br s = broad singlet, m = multiplet, app. = apparent), and coupling 
constant (Hz). 13C NMR spectra were recorded on a Varian Unity INOVA 400 (100 MHz) 
spectrometer with complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.00 
ppm). High-resolution mass spectrometry was performed on a JEOL AccuTOF DART 
(positive mode) at the Mass Spectrometry Facility, Boston College. Enantiomer ratios 
were determined by high-performance liquid chromatography (HPLC) with a Shimadzu 
chromatograph (Chiral Technologies Chiralpak AZ–H (5.0 × 250 mm), Chiralpak OD–H 
(5.0 × 250 mm)) in comparison with authentic racemic materials. Specific rotations were 
measured on a Rudolph Research Analytical Autopol IV polarimeter.  
Unless otherwise noted, all reactions were carried out with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with 
standard dry box or vacuum-line techniques. Solvents were purified under a positive 
pressure of dry argon by a modified Innovative Technologies purification system: toluene, 
benzene and hexanes were purified through a copper oxide and alumina column; CH2Cl2 
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and Et2O were purged with Ar and purified by passage through two alumina columns. 
Tetrahydrofuran (Aldrich Chemical Co.) was purified by distillation from sodium 
benzophenone ketyl immediately prior to use unless otherwise specified. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from 
Fisher Scientific) in air. 
 
Reagents and Ligands 
Allylic phosphates: prepared according to previously reported methods.7,8 
Bis[(pinacolato)boryl]methane (1.2): prepared according to previously reported 
methods.9 
Copper (I) chloride: purchased from Strem Chemicals Inc. and used as received. 
Diethyl chlorophosphate: purchased from Aldrich and used as received. 
NHC–Ag complexes: prepared following previously reported methods.10 
Sodium perborate tetrahydrate: purchased from Aldrich and used as received. 
Sodium methoxide: purchased from Strem Chemicals Inc. and used as received. 
Triethylamine: purchased from Fisher Scientific, Inc. and distilled over CaH2 prior to 
use. 
 
Representative Procedure for Cu(I)-Catalyzed Enantioselective Allylic Substitution 
with Diboron Reagents: 
An oven-dried 1 dram vial equipped with a stir bar was charged with NHC-Ag 
                                                        
(7) Jung, B.; Hoveyda, A. H. J. Am. Chem. Soc., 2012, 134, 1490–1493. 
(8) Takeda, M.; Takatsu, K.; Shintani, R.; Hayashi, T. J. Org. Chem., 2014, 79, 2354–2367. 
(9) Sun, C.; Potter, B.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 6534–6537. 
(10) (a) May, T. L.; Brown, M. K.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2008, 47, 7358–7362. (b) 
Akiyama, K.; Gao, F.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2010, 49, 419–423. 
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complex N12 (4.0 mg, 2.75 μmol) and CuCl (0.5 mg, 5 μmol) in a nitrogen-filled glove 
box. Freshly distilled THF (0.8 mL) was added to the vial and the mixture was allowed to 
stir at 22 °C for 2 h. After that, NaOMe (6.5 mg, 120 μmol) was added and the vial was 
sealed with a cap (phenolic open top cap with a red PFTE/white silicon septum) and 
electrical tape, and removed from the glove box. The solution of allylic phosphate (28.4 
mg, 0.10 mmol) and diborylmethane 1.2 (40.2 mg, 0.15 mmol) in THF (0.3 mL) was 
added to the reaction mixture through a plastic syringe and the resulting mixture was 
allowed to stir at 22 °C for 24 h. 
The mixture was passed through a short plug of silica gel and eluted with Et2O. The 
organic layer was concentrated in vacuo, and then NaBO3•4H2O (46.2 mg, 0.30 mmol), 
THF (1 mL) and H2O (1 mL) was added to the same vessel. The mixture was allowed to 
stir at 22 oC for 3 h. The mixture was extracted with Et2O and concentrated to give 
colorless oil, which was purified by silica gel chromatography to afford the desired 
product as colorless oil. 
 
(S)-2-Methyl-2-phenylbut-3-en-1-ol (1.11):  
1H NMR (CDCl3, 400 MHz): δ 7.36–7.24 (5H, m), 6.08 (1H, dd, J = 17.6, 10.8 Hz), 5.28 
(1H, dd, J = 10.8, 1.2 Hz), 5.16 (1H, dd, J = 17.6, 1.2 Hz), 3.80 (2H, d, J = 6.4 Hz), 1.44 
(3H, s), 1.35 (1H, br s). The 1H NMR matches previous report.11 Specific rotation: [α]D20 
16.3 (c 1.0, EtOH) for an enantiomerically enriched sample of 92:8 e.r., and absolute 
configuration assigned as S.5 
                                                        
(11) Ngai, M. Y.; Skucas, E.; Krische, M. J. Org. Lett. 2008, 10, 2705. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.5:0.5 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 102.487 50.276 1 77.702 92.769 
2 152.128 49.724 2 111.390 7.231 
(S)-2-(3-Bromophenyl)-2-methylbut-3-en-1-ol (1.11b): 
IR (neat): 3392 (br), 2969 (m), 2932 (m), 2875 (m), 1592 (m), 1562 (s), 1474 (s), 1416 
(s), 1071 (s), 1041 (s), 997 (s), 921 (s), 783 (s), 747 (s), 699 (s) cm-1; 1H NMR (CDCl3, 
400 MHz): δ 7.47 (1H, t, J = 1.6 Hz), 7.37-7.34 (1H, m), 7.29-7.24 (1H, m), 7.19 (1H, t, 
J = 4.0 Hz), 6.01 (1H, ddd, J = 17.6, 10.8, 1.2 Hz), 5.28 (1H, dd, J = 10.8, 1.2 Hz), 5.14 
(1H, d, J = 17.6 Hz), 3.75 (2H, d, J =  1.6 Hz), 1.39-1.38 (4H, m); 13C NMR (CDCl3, 100 
MHz): δ 147.1, 142.8, 130.2, 129.9, 129.6, 125.6, 122.7, 115.2, 69.7, 47.0, 22.6; HRMS 
(ESI+): Calcd for C11H12Br [M+H-H2O]+: 223.0112; Found: 223.0132. Specific rotation: 
[α]D20 9.8 (c 1.0, CHCl3) for an enantiomerically enriched sample of 95:5 e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OD–H column, 99.5:0.5 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 126.803 51.884 1 118.804 4.924 
2 137.815 48.116 2 126.492 95.076 
(S)-2-(3-Chlorophenyl)-2-methylbut-3-en-1-ol (1.11c): 
1H NMR (CDCl3, 400 MHz): δ 7.34-7.33 (1H, m), 7.27-7.22 (4H, m), 6.04 (1H, dd, J = 
17.6, 10.8 Hz), 5.29 (1H, dd, J = 10.0, 1.2 Hz), 5.16 (1H, dd, J = 17.6, 1.2 Hz), 3.78 (2H, 
d, J =  6.8 Hz), 1.47-1.35 (4H, m); 13C NMR (CDCl3, 100 MHz): δ 146.8, 142.8, 134.4, 
129.6, 127.4, 126.7, 125.1, 115.2, 69.7, 47.0, 22.6;  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 51.852 49.853 1 51.050 94.527 
2 69.645 50.147 2 70.920 5.473 
(S)-2-Methyl-2-(4-(trifluoromethyl)phenyl)but-3-en-1-ol (1.11d): 
IR (neat): 3380 (br), 2970 (w), 2936 (w), 1618 (w), 1412 (w), 1372 (s), 1165 (s), 1123 (s), 
1067 (s), 1016 (s), 922 (s), 838 (m), 706 (w), 606 (w) cm-1; 1H NMR (CDCl3, 400 MHz): 
δ 7.57 (2H, d, J = 7.6 Hz), 7.47 (2H, d, J = 7.6 Hz), 6.04 (1H, dd, J = 18.0, 10.4 Hz), 5.30 
(1H, d, J = 10.8 Hz), 5.14 (1H, d, J = 17.6 Hz), 3.80 (2H, s), 1.43 (3H, s), 1.40 (1H, br); 
13C NMR (CDCl3, 100 MHz): δ 148.8 (J = 2 Hz), 142.7, 128.7 (q, J = 32 Hz), 127.4, 
125.5-125.2 (m), 122.8, 120.1, 115.5, 69.6, 47.1, 22.7; HRMS (ESI+): Calcd for C12H12F3 
[M+H-H2O]+: 213.0891; Found: 213.0884. Specific rotation: [α]D20 7.4 (c 1.0, CHCl3) for 
an enantiomerically enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.5:0.5 hexanes/iPrOH, 0.5 mL/min, 220 
nm. Retention time: 66.49 min (major), 73.47 (minor). 
(S)-2-Methyl-2-(naphthalen-2-yl)but-3-en-1-ol (1.11e): 
1H NMR (CDCl3, 500 MHz): δ 7.83-7.79 (4H, m), 7.51-7.46 (3H, m), 6.17 (1H, dd, J = 
18.0, 11.0 Hz), 5.33 (1H, d, J = 11.0 Hz), 5.20 (1H, d, J = 17.5 Hz), 3.90 (2H, s), 1.54 
 17 
(3H, s); 13C NMR (CDCl3, 100 MHz): δ 143.5, 141.8, 133.4, 132.1, 128.1, 128.0, 127.4, 
126.1, 125.8, 125.6, 125.3, 114.9, 69.9, 47.2, 22.7. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm.  
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 73.261 49.915 1 70.831 94.074 
2 86.304 50.085 2 84.634 5.926 
(S)-2-(2-Methoxyphenyl)-2-methylbut-3-en-1-ol (1.11f): 
IR (neat): 3421 (br), 2936 (w), 2881 (w), 1598 (w), 1498 (s), 1462 (m), 1434 (m), 1240 
(s), 1027 (s), 914 (m), 753 (s), 700 (w) cm-1; 1H NMR (CDCl3, 400 MHz): δ 7.29 (1H, dd, 
J = 8.0, 1.6 Hz), 7.24-7.20 (1H, m), 6.94-6.88 (2H, m), 6.20 (1H, dd, J = 18.0, 10.4 Hz), 
5.16 (1H, dd, J = 10.8, 1.2 Hz), 5.03 (1H, dd, J = 18.0, 1.2 Hz), 3.98-3.93 (1H, m), 3.89-
3.84 (1H, m), 3.80 (3H, s), 1.44 (3H, s); 13C NMR (CDCl3, 100 MHz): δ 157.9, 144.0, 
132.3, 129.1, 128.0, 120.7, 113.2, 111.9, 68.5, 55.2, 47.0, 21.7; HRMS (ESI+): Calcd for 
C12H16O2 [M+H]+: 193.1229; Found: 193.123. Specific rotation: [α]D20 14.4 (c 0.5, 
CHCl3) for an enantiomerically enriched sample of 95:5 e.r. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OD–H column, 99.5:0.5 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 81.429 49.825 1 129.295 5.136 
2 93.372 50.175 2 148.027 94.864 
(S)-2-(2-Fluorophenyl)-2-methylbut-3-en-1-ol (1.11g): 
IR (neat): 3431 (br), 2926 (m), 2855 (w), 1598 (w), 1488 (m), 1447 (m), 1217 (m), 1039 
(s), 919 (w), 809 (s), 756 (s) cm-1; 1H NMR (CDCl3, 500 MHz): δ 7.37-7.34 (1H, m), 
7.26-7.22 (1H, m), 7.12-7.09 (1H, m), 7.05-7.00 (1H, m), 6.14 (1H, dd, J = 17.5, 11.0 
Hz), 5.26 (1H, d, J = 10.5 Hz), 5.09 (1H, d, J = 18.0 Hz), 3.89 (1H, d, J = 4.5 Hz), 1.48 
(3H, s);  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.5:0.5 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 52.677 48.825 1 53.195 91.974 
2 66.453 51.175 2 68.077 8.026 
(R)-2-(((tert-butyldimethylsilyl)oxy)methyl)-2-methylbut-3-en-1-ol (1.11h): 
IR (neat): 2927 (m), 1723 (s), 1470 (m), 1268 (s), 1096 (s), 1027 (m), 837 (s), 776 (m), 
709 (s) cm-1; 1H NMR (CDCl3, 400 MHz): δ 5.81 (1H, dd, J = 17.6, 10.8 Hz), 5.13 (1H, 
dd, J = 6.8, 1.2 Hz), 5.09 (1H, dd, J = 12.8, 1.2 Hz), 3.63-3.45 (4H, m), 2.52 (1H, br), 
1.00 (3H, s), 0.89 (9H, s), 0.04 (6H, s); 13C NMR (CDCl3, 100 MHz): δ 141.3, 114.5, 
70.4, 69.8, 43.0, 33.9, 29.7, 25.8, 18.4, 18.1, -5.7, -5.7; HRMS (ESI+): Calcd for 
C12H15OSi [M+H-H2O]+: 213.1675; Found: 213.168. Specific rotation: [α]D20 0.2 (c 1.0, 
CHCl3) for an enantiomerically enriched sample of 84:16 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material of benzoate derivatives; Chiralpak OD–H column, 100% hexanes, 0.2 
mL/min, 220 nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 38.643 47.222 1 36.267 15.701 
2 40.337 52.778 2 37.567 84.299 
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CHAPTER 2                                                                                                  
CATALYTIC ENANTIOSELECTIVE MULTICOMPONENT 
ALLYL CONJUGATE ADDITION 
2.1 INTRODUCTION 
Catalytic enantioselective conjugate additions are very important transformations in 
organic synthesis.12 Many kinds of catalytic reactions are reported to transfer a variety of 
functional groups, such as aryl, alkenyl and alkyl groups, to the stereogenic center with 
high efficiency and enantioselectivity. Among these reports, catalytic enantioselective 
conjugate additions of allyl groups to α,β-unsaturated carbonyl compounds are rare. One 
challenging problem would be the undesired competitive background reactions caused by 
the ligand-free allylmetal species due to their high nucleophilicity. Another issue might 
be that stable π-allyl metal complexes do not easy to undergo reductive elimination. 
                                                        
(12) For reviews on catalytic enantioselective conjugate addition, see: (a) Harutyunyan, S. R.; den 
Hartog, T.; Geurts, K.; Minnaard, A. J.; Feringa, B. L. Chem. Rev. 2008, 108, 2824–2852.  
(b) Jerphagnon, T.; Pizzuti, M. G.; Minnaard, A. J.; Feringa, B. L. Chem. Soc. Rev. 2009, 38, 1039–
1075. (c) Cordova, A. Catalytic Asymmetric Conjugate Reactions; Wiley-VCH: Weinheim, 2010. (d) 
Ji, J.-X.; Chan, A. S. C. Catalyic Asymmetric Synthesis (Ed.: I. Ojima); Wiley, Hoboken, 2010, pp. 
439–495. 
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Hoveyda group has recently reported catalytic enantioselective conjugate additions 
of propargyl and allyl groups. 13  We designed a catalytic multicomponent process 
(scheme 2.1) that begins with the formation of Cu-H species II from CuI alkoxide I, 
followed by Cu-H addition to allenyl-B(pin) to generate allylcopper intermediate III. The 
conjugate addition of allylcopper intermediate III to α,β-unsaturated malonate IV gives 
the intermediate VI, followed by ligand exchange to regenerate CuI alkoxide I and afford 
the desired conjugate addition product VII. 
 
                                                        
(13) (a) Meng, F.; Li, X., Torker, S.; Shi, Y.; Shen, X.; Hoveyda, A. H. Nature, 2016, 537, 387–393. 
(b) Li, X.; Meng, F.; Torker, S.; Shi, Y.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2016, 55, 9997-
10002. 
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A common problem for multicomponent reactions would be chemoselectivity issues 
in this process. For example, Cu alkoxide I can react with allenyl-B(pin) 2.2 to generate 
allenylcopper, which could participate in conjugate addition as well. Cu-H complex II 
can also directly add to α,β-unsaturated malonate IV to give reduction product. Besides 
all the aforementioned issues, allylcopper intermediate III could isomerize, which would 
generate linear & branched allylcopper, as well as E- & Z-isomers in a non-selective 
fashion. We hope to develop an efficient and enantioselective conjugate addition where 
side process can be minimized. 
2.2 BACKGROUND 
As for previous reports on enantioselective allyl conjugate addition, Morken and co-
workers reported Ni-catalyzed enantioselective addition of allyl-B(pin) to dienone. 
(Scheme 2.2).14 The reaction is very effective with dialkylidene ketones and favors the 
allylation of the benzylidene site in nonsymmetric substrates. The authors propose a 
mechanism involving an oxidative π-allyl formation and a 3,3’-reductive elimination 
process. 
 
                                                        
(14) Sieber, J. D.; Morken, J. P. J. Am. Chem. Soc. 2008, 130, 4978–4983. 
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In 2008, the Snapper group reported catalytic enantioselective Hosomi–Sakurai 
conjugate allylation of cyclic unsaturated ketoesters (Scheme 2.3).15 Conjugate addition 
products can be generated in up to 78% yield and >98:2 e.r. with a bisoxazole-Cu 
complex. 
 
In 2011, Shibasaki and co-workers reported the enantioselective conjugate addition 
of allyl cyanide to α,β-unsaturated thioamides 2.9 (Scheme 2.4).16 Product 2.10 is 
obtained in 87% yield and 98.5:1.5 e.r. 
 
In 2011, Feng and co-workers reported catalytic enantioselective conjugate 
allylation to coumarins (Scheme 2.5).17 They employed a dual activation strategy by 
using N,N’-dioxide-Yb(OTf)3 to activate coumarin 2.11, and using (CuOTf)2•C7H8 to 
                                                        
(15) Shizuka, M.; Snapper, M. L. Angew. Chem., Int. Ed. 2008, 47, 5049–5051. 
(16) Yanagida, Y.; Yazaki, R.; Kumagai, N.; Shibasaki, M. Angew. Chem., Int. Ed. 2011, 50, 7910–
7914. 
(17) Kuang, Y.; Liu, X.; Chang, L.; Wang, M.; Lin, L.; Feng, X. Org. Lett. 2011, 13, 3814–3817. 
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activate tetraallyltin 2.12 by transmetalation. Products are obtained in up to 99% 
yield, >19:1 d.r. and 96.5:3.5 e.r. under mild conditions.  
 
In 2016, Hoveyda and co-workers reported catalytic enantioselective 1,6-conjugate 
additions of allyl-type nucleophiles promoted by NHC–Cu complexes (Scheme 2.6).13a  
Propargyl and allyl 1,6-addition products are formed in high efficiencies, diastereo- and 
enantioselectivities. The author proposed that the transformations proceed through an 
unprecedented Cu-catalyzed 3,3’-reductive elimination.  
 
In the same year, Hoveyda and co-workers reported multicomponent catalytic 
enantioselective conjugate additions of (pin)B-substituted allylcopper to α,β-unsaturated 
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malonate (Scheme 2.7).13b Desired products are obtained in up to 83% yield and 98:2 
enantiomeric ratio. 
 
2.3 OPTIMIZATION OF REACTION CONDITIONS FOR CATALYTIC 
ENANTIOSELECTIVE MULTICOMPONENT ALLYL CONJUGATE 
ADDITION 
We started our investigation with ligand screening for the multicomponent allyl 
conjugate addition. A variety of ligands were tested, as shown in table 2.1. One major 
byproduct is malonate 2.27 derived from direct reduction of α,β-unsaturated malonate 
2.25. Reactions catalyzed by some bisphosphine ligands, such as L3, L4, L6, L7, L10 
and L11, can generate product efficiently with moderate chemoselectivity and 
enantiomeric ratio. Among them, L11 (R)-DTBM-SEGPHOS provided desired product 
2.26 in 60% yield, 82:18 e.r. with 8:1 ratio of 2.26/2.27 (entry 11). A lower catalyst 
loading (with 6 mol % of L11 and 5 mol % of CuCl) gave a similar result (entry 13). 
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Entry Ligand Conv. %b 2.26:2.27c Yield %d e.r.e 
1 L1 >98 NA <2 NA 
2 L2 >98 NA <2 NA 
3 L3 >98 4:1 52 55:45 
4 L4 >98 4:1 50 67:33 
5 L5 >98 1:1.5 21 50:50 
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6 L6 >98 6:1 58 61:39 
7 L7 >98 6:1 68 65:35 
8 L8 >98 NA <2 NA 
9 L9f >98 NA <2 NA 
10 L10 >98 2:1 38 74:26 
11 L11 >98 8:1 60 82:18 
12 SIMes >98 1:1.5 29 NA 
13g L11 >98 6:1 66 80:20 
14 - >98 <2:>98 NA NA 
a Reactions were performed under N2 atmosphere. b,c Determined by analysis of 400 MHz 1H NMR of 
unpurified mixtures. d Isolated yield of pure product. e Determined by HPLC analysis. f With 10 mol % 
of L9 and CuCl. g With 6 mol % of L11 and 5 mol % CuCl. 
 
With L11 in hand, we tried to further optimize the reaction conditions. A variety of 
conditions were tested, as shown in table 2.2. A screening of bases (entry 1-7) indicate 
that NaOPh (entry 5) can give the best result (compared with LiOMe, LiOtBu, NaOMe, 
NaOtBu, NaOAc and KOtBu) with 66% yield and 87:13 e.r. Reactions performed at 
lower temperatures are less efficient (entries  8,9 vs. 5) with lower conversion and yield, 
but with higher e.r. and chemoselectivity. The yield of 2.26 is further improved with a 
higher catalyst loading (9 mol % of L11 and 7. 5 mol % of CuCl vs of 6 mol % of L11 
and 5 mol % of CuCl) and more reagent 2.2 (3 equiv. vs. 2 equiv.), to deliver an efficient 
reaction with 98% conversion of starting material 2.25, 77% yield of conjugate addition 
product 2.26, 95:5 e.r. and >20:1 ratio of 2.26/2.27 (entry 11). 
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Entry Base Conv. %b Temp.oC 2.26:2.27c Yield %d e.r.e 
1 LiOMe 90 22 8:1 52 80:20 
2 LiOtBu >98 22 6:1 66 80:20 
3 NaOMe >98 22 NA <2 NA 
4 NaOtBu >98 22 NA <2 NA 
5 NaOPh >98 22 7:1 66 87:13 
6 NaOAc <5 22 NA ND NA 
7 KOtBu >98 22 6:1 <2 65:35 
8 NaOPh 82 4 >10:1 58 90:10 
9 NaOPh 59 -30 >20:1 42 94:6 
10f NaOPh 86 -30 >20:1 71 95:5 
11f,g NaOPh 98 -30 >20:1 77 95:5 
a Reactions were performed under N2 atmosphere. b,c Determined by analysis of 400 MHz 1H NMR of 
unpurified mixtures. d Isolated yield of pure product. e Determined by HPLC analysis. f With 9 mol % 
of L11 and 7.5 mol % CuCl. g With 3 equiv. of 2.2. 
2.4 SCOPE OF CATALYTIC ENANTIOSELECTIVE MULTICOMPONENT 
ALLYL CONJUGATE ADDITION 
With the optimum conditions in hand, we examined the substrate scope for the 
multicomponent allyl conjugate addition. As shown in scheme 2.8, halogen substituents 
(2.26c-d) are well tolerated. Sterically demanding substrate 2.26b, although less efficient, 
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works well (67% yield and 92:8 e.r.). Electron deficient 2.26f and rich (2.26e) substrates 
are suitable. Heterocycle containing substrates (2.26h-i) are also compatible with reaction 
conditions to deliver products in high efficiency (84% yield, 95:5 e.r.; 75% yield, 92:8 
e.r., respectively). Cu-H addition products, as well as Z- products are not observed in any 
of these cases. 
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2.5 FUNCTIONALIZATION OF PRODUCTS OF CATALYTIC 
ENANTIOSELECTIVE MULTICOMPONENT ALLYL CONJUGATE 
ADDITION 
Alkenyl boronic esters are broadly useful functional motifs in organic synthesis.18 
Not only they possess high chemical stability, they can also participate in a variety of 
transformations. In 2017, Yun and co-workers reported a Cu-catalyzed regio- and 
enantioselective hydroallylation of alkenyl boronates and boramides (scheme 2.9).19 
 
We tested the Cu-catalyzed enantioselective hydroallylation of alkenyl boronates as 
reported above (scheme 2.10). Under the reported conditions, we observed low 
conversion of alkenyl-B(pin) 2.26 (30~40%), and recovered non-separable mixture. 
 
                                                        
(18) (a) Ramachandran, P. V.; Brown, H. C. Recent Advances in Borane Chemistry. In 
Organoboranes for Synthesis; ACS Symposium Series 783; American Chemical Society: Washington, 
DC, 2001. (b) Matteson, D. S. Tetrahedron 1989, 45, 1859. (c) Brown, H. C.; Campbell, J. B., Jr. 
Aldrichimica Acta 1981, 14, 3. (d) Hall, D. G., Ed. Boronic Acids: Preparation, Applications in 
Organic Synthesis and Medicine, 2nd ed.; Wiley-VCH: Weinheim, 2011. 
(19) J. T. Han, W. J. Jang, N. Kim, J. Yun, J. Am. Chem. Soc. 2016, 138, 15146−15149. 
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2.6 CONCLUSION 
In this chapter, we have developed a facile multicomponent catalytic process that 
begins with a chemo- and siteselective copper–hydride addition to allenyl-B(pin) 
followed by enantioselective conjugate addition of the resulting allylcopper intermediate 
to α,β-unsaturated malonates, generating products that contain a stereogenic center and an 
easily functionalizable alkenyl-B(pin) in up to 84% yield, >98:2 E/Z selectivity and 96:4 
enantiomeric ratio. The transformations are catalyzed by chiral Cu complexes derived 
from commercially available bisphosphines. Further studies on expanding substrate scope, 
functionalization of products and application towards synthesis of valuable compounds 
are ongoing. 
2.7 EXPERIMENTAL 
General 
Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, νmax in cm−1. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, br s = broad singlet, m = multiplet, app. = apparent), and coupling 
constant (Hz). 13C NMR spectra were recorded on a Varian Unity INOVA 400 (100 MHz) 
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spectrometer with complete proton decoupling. Chemical shifts are reported in ppm from 
tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 77.00 
ppm). High-resolution mass spectrometry was performed on a JEOL AccuTOF DART 
(positive mode) at the Mass Spectrometry Facility, Boston College. Enantiomer ratios 
were determined by high-performance liquid chromatography (HPLC) with a Shimadzu 
chromatograph (Chiral Technologies Chiralpak AZ–H (5.0 × 250 mm), Chiralpak OD–H 
(5.0 × 250 mm)) in comparison with authentic racemic materials. Specific rotations were 
measured on a Rudolph Research Analytical Autopol IV polarimeter.  
Unless otherwise noted, all reactions were carried out with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with 
standard dry box or vacuum-line techniques. Solvents were purified under a positive 
pressure of dry argon by a modified Innovative Technologies purification system: toluene, 
benzene and hexanes were purified through a copper oxide and alumina column; CH2Cl2 
and Et2O were purged with Ar and purified by passage through two alumina columns. 
Tetrahydrofuran (Aldrich Chemical Co.) was purified by distillation from sodium 
benzophenone ketyl immediately prior to use unless otherwise specified. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from 
Fisher Scientific) in air. 
 
Reagents and Ligands 
Allenylboronic acid pinacol ester (2.2): purchased from Aldrich Chemical Co. and used 
as received. 
Copper (I) chloride: purchased from Strem Chemicals Inc. and used as received. 
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Diethyl allyl phosphate (2.29): purchased from Aldrich Chemical Co. and used as 
received. 
Diethyl benzylidenemalonate (2.25): purchased from Aldrich Chemical Co. and used as 
received. 
Enoate (2.25b-i): prepared according to previously reported procedures.20 
L1-L11: purchased from Strem Chemicals Inc. and used as received. 
Lithuim tert-butoxide: purchased from Strem Chemicals Inc. and used as received. 
Lithuim methoxide: purchased from Strem Chemicals Inc. and used as received. 
Poly(methylhydrosiloxane): purchased from Aldrich Chemical Co. and used as received. 
Potassium tert-butoxide: purchased from Strem Chemicals Inc. and used as received. 
SIMes chloride: purchased from Aldrich Chemical Co. and used as received. 
Sodium tert-butoxide: purchased from Strem Chemicals Inc. and used as received. 
Sodium methoxide: purchased from Strem Chemicals Inc. and used as received. 
Sodium phenoxide: purchased from Strem Chemicals Inc. and used as received. 
 
Representative Procedure for Multicomponent Allyl Conjugate Addition: 
An oven-dried 1 dram vial equipped with a stir bar was weighed and charged with 
phosphine L11 (10.6 mg, 9 μmol), CuCl (0.75 mg, 7.5 μmol) and NaOPh (14.4 mg, 150 
μmol) in a N2-filled glove box. Freshly distilled THF (1.0 mL) was added to the vial and 
the mixture was allowed to stir at 22 °C for 0.5 h. After that, PMHS (18.0 mg, 0.3 mmol) 
and allenyl-B(pin) 2.2 (49.8 mg, 0.3 mmol) was added into the vial. The vial was sealed 
with a cap (phenolic open top cap with a red PFTE/white silicon septum) and electrical 
tape, removed from the glove box, and cooled down to -78 oC before malonate (24.8 mg, 
                                                        
(20) C. F. H. Allen, F. W. Spangler, Org. Syn. 1945, 25, 42. 
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0.10 mmol) was added by a syringe. The vial was then moved into the cryocool and kept 
at -30 oC for 24 h. After that, the mixture was passed through a short plug of silica gel 
and eluted with Et2O. The organic layer was concentrated in vacuo and purified by silica 
gel chromatography to afford the desired product as solorless oil. 
 
Diethyl (E)-2-(1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-
yl)malonate (2.26): 
IR (neat): 2979 (m), 1732 (s), 1638 (m), 1365 (s), 1321 (m), 1250 (m), 1144 (s), 850 (w), 
701 (m) cm-1; 1H NMR (CDCl3, 400 MHz): δ 7.27-7.15 (5H, m), 6.37 (1H, dt, J = 17.6, 
6.8 Hz), 5.34 (1H, dd, J = 18.0, 1.6 Hz), 4.19 (2H, q, J = 7.2 Hz), 3.88 (2H, q, J =  7.2 
Hz), 3.66 (1H, d, J = 10.4 Hz), 3.57-3.51 (1H, m), 2.59-2.55 (1H, m), 1.26 (3H, t, J = 7.2 
Hz), 1.20 (12H, s), 0.95 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.2, 167.7, 
150.2, 140.4, 128.3, 128.2, 126.9, 83.0, 61.5, 61.1, 58.0, 44.7, 40.4, 24.7, 24.7, 14.0, 13.7; 
HRMS (ESI+): Calcd for C23H34BO6 [M+H]+: 417.2448; Found: 417.2455. Specific 
rotation: [α]D20 17.3 (c 1.5, CHCl3) for an enantiomerically enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 98.0:2.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 14.910 49.800 1 16.065 5.212 
2 18.564 50.200 2 19.667 94.788 
Diethyl (E)-2-(1-(2-methoxyphenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)but-3-en-1-yl)malonate (2.26b): 
IR (neat): 2979 (m), 1732 (s), 1637 (m), 1493 (m), 1365 (s), 1320 (m), 1244 (s), 1144 (s), 
1030 (m), 849 (w), 754 (m) cm-1; 1H NMR (CDCl3, 400 MHz): δ 7.18-7.02 (2H, m), 
6.85-6.81 (2H, m), 6.41 (1H, dt, J = 10.8, 6.8 Hz), 5.31 (1H, d, J = 18.0 Hz), 4.18 (2H, q, 
J = 7.2 Hz), 3.99 (1H, d, J = 14.4 Hz), 3.94-3.82 (6H, m), 2.73-2.66 (1H, m), 2.57-2.51 
(1H, m), 1.27 (3H, t, J = 7.2 Hz), 1.20 (12H, s), 0.96 (3H, t, J = 7.6 Hz); 13C NMR 
(CDCl3, 100 MHz): δ 168.6, 168.2, 157.6, 151.4, 129.8, 128.3, 127.9, 120.2, 110.7, 82.9, 
61.3, 60.9, 55.8, 55.2, 38.5, 24.7, 14.1, 13.7; HRMS (ESI+): Calcd for C24H36BO7 
[M+H]+: 447.2554; Found: 447.255. Specific rotation: [α]D20 −4.9 (c 1.5, CHCl3) for an 
enantiomerically enriched sample of 92:8 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 98.0:2.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 13.954 50.660 1 13.612 7.826 
2 14.810 49.340 2 14.398 92.174 
Diethyl (E)-2-(1-(3-bromophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)but-3-en-1-yl)malonate (2.26c): 
IR (neat): 2979 (m), 1732 (s), 1638 (m), 1365 (s), 1322 (m), 1249 (m), 1144 (s), 849 (w), 
697 (w) cm-1; 1H NMR (CDCl3, 400 MHz): δ 7.34-7.31 (2H, m), 7.15-7.13 (2H, m), 6.34 
(1H, dt, J = 18.0, 7.2 Hz), 5.35 (1H, d, J = 17.6 Hz), 4.23-4.18 (2H, m), 3.93 (2H, q, J =  
7.2 Hz), 3.63 (1H, d, J = 10.4 Hz), 3.54-3.48 (1H, m), 2.59-2.49 (2H, m), 1.28 (3H, t, J = 
7.2 Hz), 1.20 (12H, s), 1.00 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 167.8, 
167.4,149.5, 142.8, 131.4, 130.1, 129.8, 127.0, 122.3, 83.1, 61.6, 61.3, 57.7, 44.3, 40.1, 
24.7, 14.0, 13.7; HRMS (ESI+): Calcd for C23H33BBrO6 [M+H]+: 495.1554; Found: 
495.1567. Specific rotation: [α]D20 1.4 (c 2.0, CHCl3) for an enantiomerically enriched 
sample of 91:9 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 98.0:2.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 15.535 51.317 1 15.183 8.976 
2 17.464 48.683 2 16.961 91.024 
Diethyl (E)-2-(1-(4-fluorophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-
3-en-1-yl)malonate (2.26d): 
IR (neat): 2980 (m), 1731 (s), 1638 (m), 1510 (m), 1364 (s), 1320 (s), 1225 (s), 1143 (s), 
1033 (m), 839 (m) cm-1; 1H NMR (CDCl3, 400 MHz): δ 7.18-7.13 (2H, m), 6.98-6.92 
(2H, m), 6.34 (1H, dt, J = 18.0, 7.2 Hz), 5.34 (1H, d, J = 18.0 Hz), 4.20 (2H, q, J =  7.2 
Hz), 3.93-3.88 (2H, m), 3.62 (1H, d, J = 12.4 Hz), 3.56-3.50 (1H, m), 2.61-2.46 (2H, m), 
1.27 (3H, t, J = 7.2 Hz), 1.21 (12H, s), 1.00 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 
MHz): δ 168.0, 167.6, 161.7 (d, J = 244 Hz), 149.8, 136.0 (d, J = 3 Hz), 129.8 (d, J = 8 
Hz), 115.1 (d, J = 21 Hz), 83.0, 61.6, 61.2, 58.0, 43.9, 40.4, 24.7, 14.0, 13.7; HRMS 
(ESI+): Calcd for C23H33BFO6 [M+H]+: 435.2354; Found: 435.2347.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 98.0:2.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 15.659 50.945 1 15.220 6.309 
2 18.193 49.055 2 17.610 93.691 
Diethyl (E)-2-(1-(4-methoxyphenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)but-3-en-1-yl)malonate (2.26e): 
1H NMR (CDCl3, 400 MHz): δ 7.11-7.10 (2H, m), 6.81-6.78 (2H, m), 6.37 (1H, dt, J = 
18.0, 6.8 Hz), 5.35 (1H, d, J = 18.0 Hz), 4.20 (2H, q, J =  7.2 Hz), 3.90 (2H, q, J =  7.2 
Hz), 3.76 (3H, s), 3.61 (1H, d, J = 10.4 Hz), 3.52-3.46 (1H, m), 2.55-2.51 (2H, m), 1.27 
(3H, t, J = 7.6 Hz), 1.20 (12H, s), 0.98 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): 
δ 168.2, 167.7, 158.4, 150.4, 132.4, 129.3, 113.6, 83.0, 61.4, 61.1, 58.2, 55.1, 43.9, 40.5, 
24.7, 14.1, 13.8.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 94.0:6.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 17.375 50.794 1 17.044 4.185 
2 20.395 49.206 2 19.872 95.815 
Diethyl (E)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(4-
(trifluoromethyl)phenyl)but-3-en-1-yl)malonate (2.26f): 
IR (neat): 2980 (w), 1733 (m), 1638 (w),  1364 (m), 1324 (s), 1143 (s), 1069 (s), 848 (w) 
cm-1; 1H NMR (CDCl3, 400 MHz): δ 7.53 (2H, d, J = 8.0 Hz), 7.32 (2H, d, J = 8.0 Hz), 
6.31 (1H, dt, J = 18.0, 6.8 Hz), 5.35 (1H, d, J = 17.6 Hz), 4.24-4.19 (2H, m), 3.93-3.87 
(2H, m), 3.69-3.59 (2H, m), 2.63-2.52 (2H, m), 1.30-1.23 (3H, m), 1.21 (12H, s), 0.96 
(3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 167.8, 167.4, 149.2, 144.6, 129.1 (q, 
J = 29 Hz), 128.7, 125.5-125.2 (m), 122.8, 83.1, 61.7, 61.3, 57.5, 40.0, 24.7, 24.7, 14.0, 
13.6.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OD–H column, 98.0:2.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 6.411 49.635 1 6.324 9.257 
2 6.870 50.365 2 6.720 90.743 
Diethyl (E)-2-(1-(naphthalen-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)but-3-en-1-yl)malonate (2.26g): 
IR (neat): 2978 (m), 1731 (s), 1637 (m), 1362 (s), 1320 (s), 1143 (s), 1031 (m), 849 (m), 
748 (m), 479 (m) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.80-7.75 (3H, m), 7.65 (1H, s), 
7.45-7.40 (2H, m), 7.37-7.34 (1H, m), 6.40 (1H, dt, J = 17.6, 6.8 Hz), 5.38 (1H, d, J = 
18.0 Hz), 4.23 (2H, q, J =  7.2 Hz), 3.88-3.70 (4H, m), 2.69-2.66 (2H, m), 1.30-1.26 (3H, 
m), 1.18 (12H, s), 0.86 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.2, 167.7,  
150.1, 137.9, 133.3, 132.6, 128.0, 127.8, 127.5, 127.3, 126.3, 125.9, 125.6, 83.0, 61.6, 
61.2, 58.1, 44.8, 40.3, 24.7, 14.1, 13.6. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 98.0:2.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
 55 
 
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 30.861 51.851 1 30.148 4.822 
2 38.114 48.149 2 37.127 95.178 
Diethyl (E)-2-(1-(benzofuran-5-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)but-3-en-1-yl)malonate (2.26h): 
1H NMR (CDCl3, 400 MHz): δ 7.58 (1H, d,  J =  0.4 Hz), 7.43 (1H, d,  J =  1.6 Hz), 7.39 
(1H, d,  J =  8.4 Hz), 7.13 (1H, dd, J =  8.8, 1.6 Hz), 6.70 (1H, dd, J =  2.4, 0.8 Hz), 6.38 
(1H, dt, J = 18.0, 6.8 Hz), 5.36 (1H, d, J = 18.0 Hz), 4.21 (2H, q, J =  6.8 Hz), 3.88-3.83 
(2H, m), 3.71-3.61 (2H, m), 2.61-2.59 (2H, m), 1.27 (3H, t, J = 6.8 Hz), 1.19 (12H, s), 
0.90 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.2, 167.7, 154.0, 150.3, 
145.1, 134.9, 127.4, 124.7, 120.9, 111.0, 106.6, 83.0, 61.5, 61.1, 58.5, 44.6, 40.8, 24.7, 
14.1, 13.7; HRMS (ESI+): Calcd for C25H37BO7N: 474.2663; Found: 474.2674. Specific 
rotation: [α]D20 -8.3 (c 2.0, CHCl3) for an enantiomerically enriched sample of 95:5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 98.0:2.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
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Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 33.478 50.647 1 32.476 4.977 
2 39.565 49.353 2 38.203 95.023 
Diethyl (E)-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(thiophen-3-yl)but-
3-en-1-yl)malonate (2.26i): 
IR (neat): 2979 (m), 1732 (s), 1638 (m), 1363 (s), 1321 (s), 1144 (s), 849 (m) cm-1. 1H 
NMR (CDCl3, 400 MHz): δ 7.20-7.18 (1H, m), 7.01-7.00 (1H, m), 6.94 (1H, d,  J =  4.8 
Hz), 6.40 (1H, dt, J = 18.0, 6.8 Hz), 5.37 (1H, dd, J = 18.0, 1.6 Hz), 4.17 (2H, q, J =  7.2 
Hz), 3.94 (2H, q, J =  6.8 Hz), 3.72-3.66 (1H, m), 3.60 (1H, d, J =  9.6 Hz), 2.57-2.52 
(2H, m), 1.25 (3H, t, J = 6.8 Hz), 1.20 (12H, s), 1.02 (3H, t, J = 7.2 Hz); 13C NMR 
(CDCl3, 100 MHz): δ 168.1, 167.8, 150.2, 141.1, 127.2, 125.2, 122.1, 83.0, 61.5, 61.2, 
57.7, 40.2, 39.9, 24.7, 24.7, 14.0, 13.8; HRMS (ESI+): Calcd for C21H32BO6S [M+H]+: 
423.2013; Found: 423.2026. Specific rotation: [α]D20 8.3 (c 1.0, CHCl3) for an 
enantiomerically enriched sample of 92:8 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 98.0:2.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
 57 
  
Peak # Time (min) Area (%) Peak # Time (min) Area (%) 
1 20.530 50.860 1 20.189 7.996 
2 25.964 49.140 2 25.140 92.004 
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